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ABSTRACT 
The endogenous synthesis of lipids, which requires suitable dietary raw 
materials, is critical for the formation of membrane bilayers. In eukaryotic cells, 
phospholipids are the predominant membrane lipids and consist of hydrophobic 
acyl chains attached to a hydrophilic head group. The relative balance between 
saturated, monounsaturated, and polyunsaturated acyl chains is required for the 
organization and normal function of membranes. Virgin olive oil is the richest 
natural dietary source of the monounsaturated lipid oleic acid and is one of the 
key components of the healthy Mediterranean diet. Virgin olive oil also contains 
a unique constellation of many other lipophilic and amphipathic constituents 
whose health benefits are still being discovered. The focus of this review is the 
latest evidence regarding the impact of oleic acid and the minor constituents of 
virgin olive oil on the arrangement and behavior of lipid bilayers. We highlight 
the relevance of these interactions to the potential use of virgin olive oil in 
preserving the functional properties of membranes to maintain health and in 
modulating membrane functions that can be altered in several pathologies. 
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1. Introduction 
Virgin olive oil plays a pivotal role as the main source of fat in the Mediterranean 
diet, a diet that has traditionally been linked to longevity in Mediterranean 
populations and is associated with a significant improvement in health status, as 
measured by reduced mortality from several chronic diseases [1-8]. 
 
More than 90% of olive oil is formed in the mesocarp of the drupe from the fruit 
of the olive tree (Olea europaea L.). Virgin olive oil (for olive oil classification and 
definitions see ref. [9]) is obtained exclusively from fresh and healthy olives by 
physical procedures under low thermal conditions (<27 C) and is the only 
edible fat that can be consumed as a natural fruit product with no additives or 
preservatives. Spain is by far the largest producer of virgin olive oil in the world, 
accounting for approximately 50% (1,600,000 tons) of total global production 
in 2012 [10]. More recently, due to the increasing recognition of the unique 
health properties of virgin olive oil, interest in virgin olive oil production has 
extended to countries outside the Mediterranean region, such as western Africa, 
Argentina, Australia, Azerbaijan, Brazil, China, India, Japan, Mexico, New Zealand, 
South Africa, and the USA. 
 
The main bioactive constituents of virgin olive oil include monounsaturated oleic 
acid and a variety of compounds present in lower quantities (“minor 
constituents”) [3, 4, 9, 11-15; and references within the manuscript]. Almost all 
fatty acids (FAs) exist as a complex in the form of triacylglycerol, an ester 
derived from glycerol and 3 FAs (saponifiable fraction, >98%). The 
triacylglycerol content of virgin olive oil is responsible for its hydrophobicity. 
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The minor constituents (unsaponifiable fraction, up to 1.5%) contribute to the 
specific properties of virgin olive oil, including its oxidative stability and unique 
flavor, as well as its color (the pigments in virgin olive oil include carotenoids 
and chlorophylls). 
 
Cells can simultaneously acquire or import a spectrum of precursors through 
endocytosis of circulating lipoproteins of endogenous or exogenous (dietary) 
origin, which affects the biogenesis and remodeling of membranes. In this 
review, we will address the impact of the bioactive constituents of virgin olive oil 
on the modulation of membrane composition and function in the context of 
health and disease, as well as the potential therapeutic applications of these 
bioactive constituents. 
 
 
2. Virgin olive oil: major and minor bioactive constituents 
 2.1. Oleic acid 
FAs are carboxylic acids and often contain a long, unbranched aliphatic chain. 
FAs are categorized as saturated (SFA), monounsaturated (MUFA), and 
polyunsaturated (PUFA), based on their structural and chemical properties. SFAs 
do not contain any double bonds or other functional groups along the chain, 
which is fully saturated with hydrogen atoms. The principal dietary SFAs are 
palmitic (16:0) and stearic (18:0) acids, which are composed of 16 and 18 carbon 
atoms, respectively. MUFAs contain one pair of carbon atoms linked by a cis 
double bond. Oleic acid (18:1n-9), which contains 18 carbon atoms with a double 
bond at the 9th carbon from the methyl end of the FA molecule, is the major 
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dietary MUFA and represents 55 to 83% of the total FAs in virgin olive oil (Table 
1). Carbon chains containing 2 or more cis double bonds, with the first double 
bond located between either the 3rd and 4th or the 6th and 7th carbon atom from 
the methyl end of the FA molecule, belong to the n-3 or n-6, respectively, PUFA 
families. These families cannot be synthesized by the human body (double bonds 
can be introduced into all positions of the FA chain with the exception of the n-3 
and n-6 positions) and therefore must be obtained from the diet as -linolenic 
acid (18:3n-3) and linoleic acid (18:2n-6) or their long-chain PUFA derivatives. 
Of these FAs, eicosapentaenoic acid (20:5n-3), docosahexaenoic acid (22:6n-3), 
dihomo--linolenic acid (20:3n-6), and arachidonic acid (20:4n-6) are the most 
metabolically significant. The concentrations of SFAs (palmitic + stearic acids) 
and PUFAs (-linolenic + linoleic acids) in virgin olive oil range from 8 to 25% 
and from 3 to 21% of the total FAs, respectively. Some parameters, such as the 
area of production, altitude, climate, fruit variety, and stage of maturity of the 
fruit can greatly affect the FA composition of virgin olive oil [16]. 
 
Oleic acid is the primary component of virgin olive oil (83% oleic acid in 
position sn-2 of the triacylglycerols) and is also found in peanut oil (59% oleic 
acid in position sn-2 of the triacylglycerols) and canola oil (37% oleic acid in 
position sn-2 of the triacylglycerols). However, stearoyl-CoA desaturase 1 (SCD1, 
similar to the mouse orthologue mScd1), which is anchored in the endoplasmic 
reticulum (ER) of hepatocytes and adipose tissue cells [17], plays a central role 
in partitioning endogenous and exogenous (dietary) FAs into metabolically 
active or inactive pools and is the rate-limiting enzyme for the biosynthesis of 
MUFAs (mainly oleic acid) from SFAs. SCD1 catalyzes the insertion of a cis double 
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bond into the 9th carbon atom of palmitic and stearic acids. Oleic acid is a key 
component of triacylglycerols and membrane lipids [18]. Importantly, oleic acid 
is the most common FA in nature, as well as in our diet (generally, oleic acid 
supplies an amount of calories equivalent or greater than the amount provided 
by SFAs and PUFAs combined). Tight restrictions on SFA consumption (<10% of 
total daily calories; less than 7% for high-risk individuals) and PUFA 
consumption (<10%) have been recommended. By contrast, oleic acid may 
provide up to 20-25% of total daily calories. In fact, oleic acid is one of the most 
abundant FA in the human body (Table 2) [19-25]. 
 
2.2. Minor constituents 
Like other fruits and vegetables, olives synthesize a variety of compounds (>230 
“minor constituents”) in response to stress conditions including infection, 
wounds, UV radiation, and the relatively high temperatures of the Mediterranean 
climate. In contrast to other vegetable oils, which must be extracted from seeds 
using solvents to be made edible, virgin olive oil retains almost all of the 
properties of olives, including the chemical composition, biochemical status, and 
organoleptic properties. In addition to complex environmental and agronomical 
factors, the average concentration of the minor constituents in virgin olive oil 
also depends on technological factors [26]. 
 
Among the several minor constituents of virgin olive oil (Figs. 1-3), the most 
abundant fraction is hydrocarbons (squalene and, in smaller amounts, the 
carotenoids -carotene and lutein). Other minor constituents of virgin olive oil 
include phytosterols, such as -sitosterol, Δ5-avenasterol, and campesterol, 
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triterpenic compounds in the form of dialcohols (erythrodiol and uvaol) or acids 
(oleanolic and maslinic acids), and phenolic compounds, representing the polar 
fraction. The main classes of phenolic compounds in virgin olive oil are 
secoiridoids, as ester derivatives of elenolic acid in either its aglyconic form or 
glycosylated with hydroxytyrosol (oleuropein) or tyrosol (ligustroside); simple 
phenols, in the form of alcohols (tyrosol and hydroxytyrosol) or acids (p-
coumaric, o-coumaric, caffeic, ferulic, sinapic, gallic, gentisic, syringic, vanillic, 
protocathechuic, and p-hydroxybenzoic acids); hydroxyisochromans formed by 
the reaction between hydroxytyrosol and benzaldehyde or vanillin; flavonoids 
(luteolin, apigenin, and quercetin); and the lignans (+)-pinoresinol, 1-(+)-
acetoxypinoresinol, and 1-(+)-hydroxypinoresinol. The lipophilic phenols 
include tocopherols (-, -, -, and -tocopherols) and tocotrienols (-, -, -, and 
-tocotrienols), with -tocopherol as the predominant constituent in virgin olive 
oil. 
 
3. Oleic acid: membrane interactions and functions 
After ingestion, lingual and pancreatic lipases hydrolyze the ester bonds of virgin 
olive oil triacylglycerols, yielding 2 major digestion products: sn-2-
monoacylglycerols (mainly sn-2-monooleoylglycerol) and FAs (mainly oleic 
acid). These products are then taken up by enterocytes, re-esterified into 
triacylglycerols, and incorporated with other lipids (e.g., small amounts of 
cholesteryl esters, mainly cholesteryl oleoyl ester), lipid-soluble vitamins, sugars, 
and apolipoproteins (mainly apoB48) into chylomicrons for subsequent 
secretion into the bloodstream. Similarly, the liver secretes very-low-density 
lipoproteins (VLDLs), which are rich in endogenous triacylglycerols from FAs 
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synthesized de novo or taken up from the circulating pool of FAs complexed with 
albumin. The triacylglycerols of chylomicrons and VLDLs undergo hydrolysis by 
lipoprotein lipase, which is located at the surface of cells. The uptake of FAs from 
the cell surroundings has long been thought to occur via simple diffusion, a 
passive process dependent on the activity of intracellular metabolism. This 
process involves the creation of a trans-membrane, downhill concentration 
gradient and includes the flip-flop molecular mechanism of FA transport [27] 
and membrane transporters (e.g., FABPpm, FAT/CD36, FATP family proteins, 
and caveolin-1), which facilitate FA endocytosis. In addition, chylomicrons and 
VLDLs, which may or may not be affected by partial hydrolysis, can be 
recognized by membrane receptors (e.g., apoB48 and VLDL receptors) [28-31], 
internalized, and directed to the endosomal-lysosomal system. Here, the sn-1(3)-
ester bonds in triacylglycerols and the C-3 ester bond in cholesteryl esters are 
hydrolyzed by lysosomal acid lipase, which produces significant amounts of 
intracellular oleic acid and sn-2-monooleoylglycerol for membrane biogenesis, 
either by acylation of glycerophosphate to phosphatidic acid (via the Kennedy 
pathway) or by remodeling of de novo synthesized glycerophospholipids via 
deacylation-reacylation or via the monoacylglycerol pathway. The regular 
consumption of virgin olive oil increases the concentration (up to 15%) of oleic 
acid among the plasma membrane lipids [32-34]. 
 
3.1. Oleic acid in membrane lipid structure 
Cell membranes contain hundreds of different lipid species, which can be 
categorized into 3 main classes: glycerophospholipids, sphingolipids, and sterols 
(cholesterol in animals) (Fig. 4). Cholesterol contains a 4-membered 
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cyclopentanophenanthrene ring structure, a hydroxyl group, and a short 
hydrophobic tail and imparts stiffness to membranes, accentuating the potential 
hydrophobic incompatibility between the hydrophobic transmembrane domains 
of proteins and the lipid bilayer core [35]. Additional complexity of 
glycerophospholipids is achieved through differences in the FA chains and their 
linkages by ester bonds in the sn-1 and sn-2 positions and by alkyl ether or 
alkenyl ether bonds in the sn-1 position of the glycerol backbone. The lipid 
backbone of sphingolipids is one molecule of ceramide (sphingosine amide 
linked to a FA), which can be further modified and extended with a 
phosphocholine head group or glycans to form sphingomyelin or 
glycosphingolipids, respectively [36]. A considerable part of our genome is 
required to synthesize, metabolize, and regulate the pool of FAs for de novo 
biogenesis of membranes, and the role of exogenous (dietary) FAs in these 
processes remains largely unknown. 
 
The incorporation of oleic acid into the phospholipids of the cell membrane can 
regulate the membrane structure and, in turn, alter the biophysical properties of 
the membrane. The lamellar phase is recognized as the most common lipid 
arrangement and is oriented perpendicular to the membrane surface in cells. The 
fluid lamellar phase (L or liquid crystalline) is found in most membrane regions 
and domains, such as coated pits, caveolae, synaptosomes, or lipid rafts [liquid-
ordered (l0) phase]; however, membrane lipids can also organize into non-
lamellar phases (L frustrated membranes), including hexagonal (HI and HII), 
cubic (micellar and bicontinuous), and rhombohedral phases [37]. Unlike stearic 
acid and elaidic acid (trans-18:1n-9), oleic acid favors the organization of 
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membranes into HII non-lamellar phases, which drastically changes the 
temperature range of the stability of the single L phase, decreasing the 
lamellar-to-hexagonal (L-to-HII) phase transition temperature in lipid 
membranes [38-40]. This propensity of oleic acid to stabilize the HII phase and to 
induce a negative curvature strain on lipid bilayers is related to the molecular 
shape of oleic acid. The cis double bond of oleic acid produces a bend at a 120° 
angle in the middle of the carbon chain that confers a boomerang-shaped 
structure. In elaidic acid (the trans isomer of oleic acid), the 2 parts of the carbon 
chain are almost linear, similar to stearic acid, resulting in a rod-shape structure. 
Linear molecules pack together closely in a given space and cause little 
disorganization of the lipid bilayer, whereas bent molecules cannot pack 
together to form such ordered and rigid arrays. The kinked lipid chain of oleic 
acid reduces the order within the lipid bilayer, helps to maintain the hydration 
level, and increases membrane fluidity [41, 42]. Oleic acid and 2-hydroxyoleic 
acid (a synthetic, hydroxylated analog of oleic acid) were recently reported to 
induce lateral lipid heterogeneity in a model mimicking cell membrane structure 
[43]. Both FAs have a similar ability to modulate the liquid-ordered/liquid-
disordered structure ratio and the microdomain lipid composition, conceivably 
affecting lipid rafts [44, 45]. The effects of different naturally occurring FAs 
(stearic, -linolenic, linoleic, eicosapentaenoic, docosahexaenoic, and 
arachidonic acids) and the corresponding synthetic 2-hydroxylated FA 
derivatives were also compared, but the greatest disordering effect was caused 
by oleic acid and 2-hydroxyoleic acid, suggesting that the presence of an 18-
carbon acyl chain in combination with a single cis double bond produced the 
most potent reorganizing effect on the model membranes. 
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3.2. Oleic acid in membrane lipid function 
Oleic acid may have important consequences as an environmental factor by 
altering some targeted molecular functions in the cell through the modulation of 
membrane properties, while either embedded in the membrane or in its free 
form upon release from the sn-2 position of phospholipids via phospholipases. In 
general, different proteins interact with specific regions of the membrane, which 
are clearly aligned into the l0 and L organizations [37]. For example, sterol 
regulatory element-binding proteins (SREBPs) belong to a family of transcription 
factors that orchestrates the expression of a broad array of genes required for 
the synthesis of cholesterol [by transcription of 3-hydroxy-3-methylglutaryl CoA 
(HMG-CoA) reductase] and FAs (by transcription of SCD1)[46]. SREBPs are 
anchored in the membrane of the ER via 2 trans-membrane domains and are 
subject to negative feedback regulation by cholesterol and FAs [47]. This 
feedback mechanism is based on the ability of unsaturated FAs to reduce 
degradation of insulin-induced gene 1 (INSIG1), an ER membrane protein that 
plays a crucial role in the SREBP cleavage-activating protein (SCAP)/SREBP 
transport system for cholesterol synthesis and uptake [48, 49]. After 
ubiquitylation of INSIG1, oleic acid but not stearic acid blocks the binding of 
ubiquitylated INSIG1 with the ubiquitin-like (UBX)-domain-containing protein 8 
(UBXD8), thereby circumventing ER-associated degradation of INSIG1 by 
stabilizing INSIG1. INSIG1 then binds the polytopic membrane protein SCAP, 
blocking the proteolytic activation of SREBP. This decrease in cellular levels of 
cholesterol has been shown to induce a rearrangement of lipid rafts, thereby 
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affecting the localization and activity of integral proteins, including platforms 
(e.g., FAT/CD36) that facilitate the binding and uptake of MUFAs and PUFAs [50]. 
 
As an example, one role for oleic acid in this complex dynamic motion of cross-
sectional distribution in membrane lipids, which stabilizes the bilayer structure 
and regulates the embedded proteins therein, has been proposed for both the 
catalytic and proton-translocase activities of urothelial V-ATPase [51]. 
Comparison of the effects of the supply of oleic or linoleic acid to superficial 
umbrella cell membranes of the urinary bladder mucosa revealed that the ATP 
hydrolytic activity of V-ATPase increases while the V-ATPase proton 
translocation rate decreases in oleic acid-rich membranes of urothelial endocytic 
vesicles. Similar findings were observed when the activity of the Na/K-ATPase 
was explored in reconstituted systems containing membrane lipids bearing FA 
chains of different lengths and degrees of unsaturation, supporting an 
uncoupling or slippage phenomenon analogous to that observed in P-ATPase-
type ion pumps [52]. Accordingly, oleic acid is proposed to mediate an increase 
in the minimal hexagonally packed particle size and create an appropriate 
topological setting for optimal ATPase function in the membrane urothelium. 
 
Due to its ability to organize membranes into L frustrated lamellar phases, oleic 
acid facilitates membrane docking and activity of other amphitropic proteins. 
Thus, L domains delineate regions for the recruitment and interaction of 
heterotrimeric G proteins, G-protein-coupled receptors (GPCRs), and related 
signaling molecules; by contrast, l0 regions form domains that enable the 
interaction of dissociated G subunits from the G dimers with effector proteins 
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[37, 53]. GPCRs, which are the largest family of membrane-spanning proteins 
(~800 members in the human genome), can detect an expansive array of 
extracellular signals or ligands, including photons, ions, odors, pheromones, 
hormones, and neurotransmitters [54, 55]. In addition to oleic acid-induced 
rearrangement of lipid bilayer structure into HII nonlamellar phases, the 
activation of heterotrimeric G proteins induces conformational changes in 
the immediate lipid environment. The G subunit exchanges bound GDP for GTP 
and dissociates from the G dimer, which retains its affinity for hexagonal-
phase membrane regions close to GPCRs [56]. Post-translational modification of 
heterotrimeric G proteins, including myristoylation, palmitoylation, and 
isoprenylation, also favors the anchoring of proteins to the membrane and the 
formation of non-lamellar-prone regions [56]. Furthermore, oleic acid regulates 
G-proteins concentrated in lipid raft/caveolae domains. The G-protein-coupled 
growth hormone (GH) secretagogue receptor (GHSR), which is activated by 
ghrelin, has been shown to assemble into lipid rafts [57]. Ghrelin binds to GHSR 
and provokes increased levels of intracellular diacylglycerol, inositol 1,4,5-
triphosphate (InsP3), and Ca2+ by the action of phospholipase C1 (PLC1/) 
on membrane phosphatidylinositol via Gq/11 proteins [58]. Oleic acid markedly 
improves the response of GHSR to ghrelin via a mechanism that involves the 
suppression of ligand-induced receptor internalization by blocking GHSR 
membrane-trafficking and uncoupling GHSR from the endocytic pathway [59]. 
Notably, the responses of other GPCRs, such as the 5-hydroxytryptamine 7A (5-
HT7A) receptor, are selectively stimulated by oleic acid, which confers more 
efficient ligand coupling of the 5-HT7A receptor with Gs subtypes of G proteins 
 16 
in the environment of lipid rafts [60]. Therefore, oleic acid provides multiple 
adaptive membrane sites for the plasticity of GPCRs, whereas G-proteins 
promote and perpetuate the concurrence of dynamic multi-domain systems of 
non-lamellar membranes with fluid lamellar phases. 
 
3.3. Oleic acid in membrane lipid therapy 
Accumulating data from multiple lines of evidence suggest that dietary FAs are 
linked not only to the promotion of health but also to the pathogenesis of 
disease. In particular, oleic acid from virgin olive oil has been shown to have 
beneficial effects in reducing the risk of major chronic diseases [3, 9, 11, 12, 15], 
many of which are associated with abnormalities in the type and/or abundance 
of the lipids in cell membranes [37]. 
 
In contrast to the consumption of soybean oil (which is rich in linoleic acid and 
low in oleic acid), virgin olive oil intake has been shown to induce a marked 
reduction in blood pressure in hypertensive animals [61]. This effect was not 
only acute (with a post-prandial peak at 2-4 h) and stable for 3-4 days but was 
also sustained after the administration of virgin olive oil for 2 weeks. 
Importantly, the administration of oleic acid, but not stearic or elaidic acid, 
mimicked the hypotensive effects of virgin olive oil. These findings suggest a 
scenario in which the signaling pathways of adrenergic receptors (- and -
adrenoreceptors), key elements in the central and peripheral control of blood 
pressure, are affected by the increase in HII-prone membrane regions in 
response to the administration of virgin olive oil or oleic acid. Several lines of 
evidence indicate adaptive changes in the bilayer structure to support the 
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regulation of the 2-adrenoreceptor/G protein/adenylyl cyclase-cAMP/protein 
kinase A (PKA) vasodilatory pathway [62-64]. First, membranes from the aorta 
of animals feature reduced expression of G-proteins, including Gi2, Gi3, Gq/11, 
and PLC1/. Second, the reduction in blood pressure correlated with a 
decrease in the L-to-HII phase transition in aortic membranes and an increase 
in the dose of oleic acid administered to the animals. The effect of oleic acid on 
blood pressure reduction is mediated, at least in part, by an enhanced 
production of vasodilatory stimuli (e.g., cAMP and PKA) and a decrease in 
vasoconstriction pathways (InsP3, Ca2+, diacylglycerols, and Rho kinase). This 
conclusion is supported by earlier studies demonstrating that the ingestion of 
virgin olive oil reduces blood pressure [32, 65] as well as the need for 
antihypertensive medication [66] in humans. 
 
Glucose uptake from the bloodstream is the rate-limiting step in whole-body 
glucose utilization and is regulated by specific transporter GLUT membrane 
proteins. Normal glucose transport and utilization is critical for preventing 
glucose intolerance that leads to insulin resistance and the development of type 
2 diabetes [67]. Members of the GLUT family (which includes 14 GLUT proteins 
in humans) are encoded by the solute carrier member 2 (SLC2) genes and are 
composed of 500 amino acid residues. GLUT family members are categorized 
into 3 classes based on sequence similarity: Class 1 (GLUTs 1-4, 14), Class 2 
(GLUTs 5, 7, 9, and 11), and Class 3 (GLUTs 6, 8, 10, 12, and HMIT). GLUTs are 
integral membrane proteins that contain 12 membrane-spanning helices, a 
single N-linked glycosylation site, and a relatively large, central cytoplasmic 
linker domain and feature topologies in which both their N and C termini are 
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exposed on the cytoplasmic side of the membrane. GLUT4 is the predominant 
isoform expressed in insulin-sensitive tissues, fat, and muscle. The insertion of 
GLUT4 into the plasma membrane and fusion with insulin-dependent docked 
GLUT4-containing vesicles is governed by the ratio of unsaturated FAs and SFAs 
in the phospholipids of model membranes [42], suggesting that membranes rich 
in oleic acid and poor in SFAs have increased flexibility and promote the capacity 
for GLUT4-dependent glucose transport into cells. In a mouse skeletal cell line, 
oleic acid has been shown to reverse SFA-induced impairment of insulin-
responsive GLUT4 recycling by preventing aberrant PKC activation [68]. These 
findings are in agreement with human studies demonstrating that dietary fats 
rich in oleic acid and poor in SFAs improve insulin sensitivity in the post-
prandial state [69, 70]. Type 2 diabetes is commonly linked with nonalcoholic 
fatty liver disease; however, the impact of FAs on hepatic membranes and the 
intolerance of hepatic cells to insulin remain poorly understood and 
controversial [71]. More evident is the protective effects of oleic acid, when 
incorporated into hepatic membranes, against models of drug-induced liver 
toxicity [72] or aging-related liver apoptosis [73]. 
 
There is increasing evidence that lipid rafts may be targets for neuronal 
development and regeneration, highlighting the potential for lipid-based 
strategies against progressive neurodegenerative disorders such as Alzheimer’s 
disease (AD) [74, 75]. Neuronal lipid rafts are involved in cellular polarity as well 
as pro-survival and pro-growth receptor signaling pathways for neuronal 
sprouting [76] and are found in the membrane sites surrounding pre- and post-
synaptic proteins [77]. An additional event in neuronal membrane repair is the 
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coalescence of smaller-scale lipid rafts into larger lipid rafts through lateral 
membrane distribution, which occurs via lipid-lipid and lipid-protein 
interactions. In neurons, oleic acid activates peroxisome-proliferator-activated 
receptors, promoting axonal growth, neuronal clustering, and the transcription 
of key genes for neuronal differentiation, including neurogenic basic helix-loop-
helix/neuronal differentiation protein-2 (NeuroD2), axonal growth-associated 
protein-43 (GAP43), and microtubule-associated protein-2 (MAP2) [78-80] 
Detailed postmortem analysis of FAs in lipid rafts in the frontal cortex grey 
matter of patients who suffered from severe Alzheimer’s-type dementia 
compared to samples from neurologically normal individuals revealed a 
significant decrease in oleic and docosahexaenoic acids [74]. The most striking 
observation was the negative relationship between oleic and stearic acids in lipid 
rafts. This observation suggests that oleic acid is important for preserving the 
homeoviscous state of membranes in neuronal cells. In support of this concept, 
oleic acid decreases the levels of the toxic amyloid- peptide, which reciprocally 
interacts with cholesterol in lipid rafts [81], and amyloid plaques in a mouse 
model of AD [82]. Furthermore, the incorporation of oleic acid into membranes 
of neuroblastoma cells reduces the toxic effects of palmitic acid and rescues cells 
from apoptosis [83]. The incorporation of oleic acid into the brain mitochondrial 
membranes after the administration of virgin olive oil could also reduce 
oxidative stress associated with age [84]. 
 
The deprotonated form of oleic acid also plays an active role as a lipid cofactor of 
partially unfolded -lactalbumin in the tumoricidal action of the oligomeric 
complex HAMLET (human -lactalbumin made lethal to tumor cells), which 
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induces membrane disruption in tumor cells but not healthy cells [85-89]. In 
contrast to SFAs, PUFAs, and trans-MUFAs, oleic acid shares specific structural 
features required for both optimal HAMLET formation and engagement of 
targets involved in tumor cell death. Membrane binding studies with a HAMLET-
like substance (BLAOA, bovine -lactalbumin complexed with oleic acid) suggest 
that acyl-chain mismatch or immiscibility of membrane lipid components may 
provide local sites for HAMLET interaction and accumulation. The negative 
intrinsic curvature of oleic acid and the bilayer-penetrating helix in the partially 
unfolded -lactalbumin more easily disrupt the membrane by blebbing, with 
subsequent shedding of small lipid aggregates, causing the membrane to collapse 
[90]. In addition to interaction with tumor cell membranes, HAMLET becomes 
rapidly internalized and translocates into the nucleus [91]. The conserved death 
response of tumor cells to HAMLET is dependent on oncogenic transformation, 
proteasome inhibition, nucleosome-histone binding, mitochondrial damage, and 
ion channel activation. The interactions of HAMLET with membranes as well as 
subsequent biological perturbations in tumor cells all require both the protein 
and oleic acid. 
 
4. Minor constituents: membrane interactions and functions 
4.1. Squalene 
Squalene is a polyunsaturated aliphatic hydrocarbon that contains 6 isoprene 
units. It is structurally related to -carotene, ubiquinol-10 (reduced form of 
coenzyme Q10), and vitamins K1, D, and E. In virgin olive oil, squalene is protected 
from oxidation, and squalene confers stability to virgin olive oil [92, 93]. The 
content of squalene in virgin olive oil ranges from 800 to 12000 mg/kg, 
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accounting for more than 50% of the unsaponifiable fraction of virgin olive oil. In 
humans, approximately 60 to 85% of dietary squalene (up to 200 mg/day) is 
absorbed and distributed ubiquitously by triacylglycerol-rich lipoproteins in 
tissues, with the greatest accumulation in the skin [94]. However, squalene can 
be endogenously synthesized by sequential reactions in which HMG-CoA is first 
converted to farnesyl pyrophosphate, followed by head-to-head condensation of 
2 molecules of farnesyl pyrophosphate catalyzed by squalene synthase, and 
reduction by NADPH to yield squalene. Squalene is an important precursor in the 
formation of eukaryotic sterols and bacterial hopanoids. For the biosynthesis of 
cholesterol, the enzymes squalene monooxygenase and oxidocyclase convert 
squalene into the cyclic derivative lanosterol, which is converted to cholesterol 
via a series of 19 reactions. SREBPs mainly regulate the transcription of the rate-
limiting enzyme HMG-CoA reductase [95]. However, cholesterol can also feed 
back to stimulate the proteasomal degradation of squalene monooxygenase as an 
additional post-translational control point in the regulation of sterol 
biosynthesis pathways and to preserve the demand for the isoprenoids farnesol 
and geranylgeraniol [96]. Farnesylation and geranylgeranylation of members of 
the Ras superfamily of GTPases and other membrane proteins have been shown 
to be critical in the correct targeting of these proteins to the inner surface of the 
plasma membrane [53]. 
 
In spite of its nonpolar nature, squalene can be partitioned within the 
hydrophobic core of the lipid bilayer, with the extended length or the coiled 
conformation [97] oriented parallel to the membrane phospholipid chains and 
in the center plane of the bilayer. In this conformation, squalene plays a major 
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role in maintaining the electrochemical gradient that moves ions across 
membranes [98]. Studies of model membranes of giant vesicles, which mimic the 
native environment of mammalian cells for the study of membrane lipid-protein 
interactions, have revealed that squalene increases the polarity and hydrophobic 
interactions of reconstituted trans-membrane-spanning regions of pore-forming 
proteins such as aquaporins, facilitating the functional regulation of these 
proteins as well as the trans-membrane route for water movement [99]. The 
stabilizing effects of squalene on membranes are related to the increased rigidity 
and size of regions adopting the inverse hexagonal HII phase [100, 101]. This 
dynamically folded conformation of squalene is retained when linked to 
gemcitabine, a synthetic tumoricidal pyrimidine nucleoside, leading to self-
organized, stable, and mono-dispersed nanoparticles composed of inverse 
hexagonal phases that increase gemcitabine amphipathy and improve 
gemcitabine diffusion through lipid membranes [102, 103]. Grafting of the 
squalenoyl moiety onto the gemcitabine molecule accelerates gemcitabine 
diffusion within cholesterol-rich domains, indicating squalenylation as a new 
nanotechnology platform for targeted delivery of drugs with anticancer and 
antiviral properties [104, 105]. 
 
The natural enrichment of squalene in skin surface lipids suggests that this 
terpene molecule protects against external chemical, physical, or microbial 
signals and stressors on the skin surface [94]. The most intensely researched 
field is solar UV irradiation (UVB, 290-320 nm; UVA, 320-400 nm), with efforts 
attempting to target the increased risk of tumor development associated with UV 
overexposure. Molecules such as DNA, trans-urocanic acid, melanin precursors, 
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tryptophan, and endogenous or bacterial porphyrins can selectively absorb in 
the UV wavelength range (mainly UVA) and hence catalyze oxidative cytostatic, 
cytotoxic, or immunomodulating photoreactions. When the -tocopherol and 
ubiquinol-10 line of defense is overwhelmed, a wide range of relatively 
hydrosoluble by-products of varying polarity and reactivity are rapidly 
generated by oxidative degradation of squalene, which is the most efficient 
quencher of singlet oxygen in skin surface lipids [94, 106]. Oral administration of 
squalene decreases UV-induced DNA damage and prevents photo-aging in 
human skin [107]. In addition to its radical scavenging capacity (either alone or 
in virgin olive oil) in membranes and skin disorders [108, 109], squalene is 
effective against several degenerative diseases [4, 110-112] and has been used as 
a vaccine adjuvant [113]. 
 
 4.2. -Carotene and lutein 
Carotenoids are polyenoic terpenoids with 8 condensed isoprene units 
containing conjugated trans double bonds. They include the family of carotenes 
(e.g., β-carotene) and xanthophylls (e.g., lutein). Carotenes are pure 
hydrocarbons and contain no oxygen atoms, whereas xanthophylls contain 
oxygen atoms within hydroxyl groups and/or epoxides. Carotenoids are 
ubiquitous constituents in the membranes of all photosynthetic organisms and 
are essential for the assembly and stability of protein complexes and for 
membrane dynamics via carotenoid-lipid-protein interactions in thylakoid 
membranes [114]. They also have photoprotective properties and participate in 
protecting elongation factors of the translational machinery from stress damage 
in the membranes of green plants and other types of photosynthetic organisms. 
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Carotenoids cannot be synthesized by vertebrates de novo and thus are 
sequestered from the diet. In virgin olive oil, the content of major carotenoids 
ranges from 4 mg/kg for β-carotene to 10 mg/kg for lutein, although virgin olive 
oil also contains β-cryptoxanthin and 5,6-epoxy xanthophylls, including 
neoxanthin, violaxanthin, antheraxanthin, and their furanoxides [115, 116]. 
Carotenoids are susceptible to reactions including isomerization (trans to cis) 
and oxidation, which increase the average shelf life of virgin olive oil [117]. 
 
Carotenoids levels in human blood and tissues are critical for maintaining human 
health. In the intestinal mucosa, approximately half of the dietary β-carotene is 
irreversibly converted to 11-cis-retinal via β-carotene 15,15’-monooxygenase 
(BCMO1) activity. Retinal is then reduced to retinol (vitamin A) by retinol 
dehydrogenases (stoichiometric conversion of 2 mol of retinol formed per 1 mol 
of β-carotene cleaved) [118, 119]; the β-ionone ring also converts pro-vitamin A 
(1 mol of retinol) to β-cryptoxanthin [120]. Retinal can also be oxidized to 
retinoic acid. The capacity of the liver to metabolize β-carotene is 4 times greater 
than that of the intestine [121]. The absorption of retinol and intact carotenoids 
is affected by several dietary factors, including the food matrix and interactions 
between carotenoids and other food components such as fiber, lipids, 
phytosterols, and other carotenoids [120, 122]. Lutein is the most abundant 
carotenoid in human triacylglycerol-rich lipoproteins after the ingestion of virgin 
olive oil [123]. The retinol metabolite retinoic acid, via retinoic acid and X 
receptors, may modulate the expression of the homeobox transcription factor 
ISX, which represses the expression of BCMO1 and membrane protein 
transporters involved in retinol and carotenoid intestinal absorption [120, 124]. 
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In biological membranes, carotenoids are present as carotenoid-protein 
complexes and as direct components of the lipid phase, demonstrating an ability 
to form self-assemblies [125]. The conformation of carotenoids in membranes is 
of great importance because the energy associated with spectroscopic 
transitions is directly related to the antioxidant properties exhibited by 
carotenoids in lipid environments [126]. According to the most recent study of 
atomistic molecular dynamics simulations of β-carotene and zeaxanthin (a 
structural isomer of lutein) immersed in a model lipid membrane [127], β-
carotene can adopt a relatively flat profile along tilt angles of the polyenic chain 
with respect to the membrane normal axis from 90˚ (perpendicular to lipid 
tails) to 35˚. Three minimal energy profiles for the simulations of β-carotene 
were observed at 90˚, 60˚, and 40˚, indicating substantial variability of the 
orientation of β-carotene within membranes. The orientation axis of β-carotene, 
which is nearly parallel with the membrane surface within hydrophobic tails, 
displays a broad distribution of the β-ionone ring centered at one of the leaflets. 
The average tilt angle for zeaxanthin was lower (approximately 30˚), likely due 
to electrostatic interactions between the hydroxyl groups of zeaxanthin with the 
polar lipid heads of the membrane. By contrast, the entire  ring of lutein can 
rotate around the C6’-C7’ bond, which facilitates the interaction of the hydroxyl 
groups located at the opposite ends of the molecule with the same polar 
membrane surface [128] and the unambiguous orientation following the pattern 
of zeaxanthin and parallel with respect to the plane of the membrane [129]. This 
result is in agreement with a specific position of lutein involving one membrane-
spanning segment and one horizontally oriented segment and with the tendency 
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of lutein to accumulate in the liquid-disordered phase of membranes [130]. 
These studies are also consistent with the β-carotene-mediated induction of 
membrane lateral asymmetry by lateral diffusion and a decrease in the lipid 
membrane surface area, as opposed to the rigidity of membranes containing 
lutein [114, 131]. The lower effective conjugated chain length for β-carotene 
predicts a lesser antioxidant character than lutein within membranes through 
enhanced charge donation and reduced charge acceptance [126, 132]. 
Differences in the membrane spatial distribution of β-carotene and lutein, as well 
as subsequent differences in their antioxidant properties, may constitute an 
advantage to synergistically trap in-tandem (lutein  β-carotene) triplet-excited 
molecules of sensitizers, singlet oxygen, or free radicals and to prevent the 
propagation cycle of lipid peroxidation from the interface of the membrane to 
the inner region of the membrane. In support of this notion, there is evidence 
that unpaired electrons flow from the oxidative-derived radical cations of 
astaxanthin, which is anchored in the lipid/water interface, to β-carotene in the 
inner portion of the membrane. The resulting β-carotene radical cation tends to 
rotate and move toward the polar interface in the membrane, facilitating the 
regeneration of β-carotene by interaction of the β-carotene radical cation with 
ascorbate or -tocopherol [133]. 
 
In the rod outer segment disc membranes of photoreceptor cells, the visual 
pigment rhodopsin is a retinal photoreceptor protein (a prototypical GPCR) of 
bipartite structure consisting of the transmembrane protein opsin and the light-
sensitive chromophore 11-cis-retinal. The reactions that eventually result in the 
conversion of light energy (photons) into a photoreceptor electrical response 
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require a constant supply of 11-cis-retinal from β-carotene and pro-vitamin A 
carotenoids. The retina is very sensitive to oxidative stress and lipid 
peroxidation due to abundant illumination, high respiratory demands for 
oxygen, and a large presence of docosahexaenoic acid, which contains 6 double 
bonds and thus is easily oxidized. To prevent oxidative damage to the retina, 
lutein (zeaxanthin and meso-zeaxanthin a metabolite of lutein) accumulates at 
very high concentrations in the macula lutea (up to 1 mM in the central fovea) 
via the involvement of specific carotenoid-binding proteins [StAR-related lipid 
transfer domain protein 3 (StARD3), for lutein] [134]. Lutein exhibits high 
efficiency in protecting against lipid peroxidation in membranes composed of 
raft-forming mixtures as well as in models of photoreceptor outer segments 
[135] and modulates the properties of lipid raft functions around membrane 
proteins such as the transient receptor potential A1 (TRPA1) ion channel in 
primary sensory neurons [136]. There is clinical evidence that lutein, β-carotene, 
and vitamins C and E reduce the risk of age-related macular degeneration [137, 
138]. These carotenoids have also been proposed to favor optical density of the 
macular pigment [139] and protect against age-related cataracts [140], cognitive 
decline [141], atrial fibrillation [142], osteoporotic fractures [143], and vascular 
aging [144]. 
 
 4.3. -Sitosterol, Δ5-avenasterol, and campesterol 
While cholesterol is the major sterol in animals, β-sitosterol, Δ5-avenasterol, and 
campesterol, in addition to brassicasterol and stigmasterol, are the most 
commonly occurring sterols (phytosterols) in the plant kingdom. These sterols 
are structurally similar and contain 4 strongly hydrophobic hydrocarbon rings 
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(planar steroid nucleus), a hydroxyl group at the 3-carbon atom of the A-ring, 
and an alkyl tail (side chain). Therefore, these molecules display amphipathic 
properties. Phytosterols differ from cholesterol only by an additional ethyl group 
(β-sitosterol) or methyl group (campesterol) at the 24-carbon atom or by an 
additional trans double bond at the 22-carbon atom (stigmasterol, as compared 
to brassicasterol) in the side chain. Carbon atom 24 in β-sitosterol and 
campesterol has R chirality, whereas the equivalent carbon atom in 
brassicasterol and stigmasterol has S chirality and lower flexibility due to the 
trans configuration of the side chain double bond [145]. Mammals do not 
synthesize phytosterols endogenously. The sterol β-sitosterol is the most 
abundant in virgin olive oil, comprising 80% to 92% of the total sterols (at least 
1000 mg/kg, with a maximum of 3000 mg/kg). Following β-sitosterol, the most 
important sterols in virgin olive oil are Δ5-avenasterol (4-14%) and campesterol 
(0.5-4%). These constituents help maintain virgin olive oil stability by inhibiting 
polymerization reactions during heating at frying temperature. The sterol profile 
is affected by the olive fruit variety and the degree of ripening [146, 147] and is 
considered a fingerprint for authentic virgin olive oil [148, 149]. 
 
When β-sitosterol is added to mixed micelles (model intestinal solutions) 
containing bile salts, phosphatidylcholine, FAs, and cholesterol, there is a 
specific, sharp decrease in the maximum solubilization of cholesterol that is 
dependent on the preferential solubilization of β-sitosterol at similar micellar 
solubilization sites according to the strength of affinity [150]. This restriction 
due to dynamic competition of cholesterol and β-sitosterol in processes of self-
assembly of nutrients in the intestinal lumen may explain the ability of β-
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sitosterol to decrease the rate of cholesterol transport to the intestinal wall, 
which is one of the main molecular mechanisms of phytosterol action on 
cholesterol plasma levels. The polytopic Niemann-Pick C1-Like1 (NPC1L1) trans-
membrane protein is required for phytosterol (and cholesterol) entry in 
enterocytes [151] . Phytosterols and non-esterified cholesterol are pumped back 
into the intestinal lumen via the ATP-binding cassette sub-family G-member 
proteins ABCG5 and ABCG8 or may be transported to the basolateral membrane 
of the enterocyte for ABCA1 (ATP-binding cassette sub-family A member 1)-
mediated biogenesis of HDLs (high-density low lipoproteins), whereas 
cholesterol is esterified via the enzyme acetyl-coA acetyltransferase 2, packed 
into chylomicrons, and drained into the lymph system [152]. These complex 
mechanisms are responsible for the assimilation of approximately 50% of 
dietary cholesterol and less than 5% of phytosterols. Notably, virgin olive oil 
intake induces an increase in the plasma levels of β-sitosterol, which is inversely 
correlated with the intestinal absorption of dietary cholesterol and the plasma 
levels of total cholesterol and LDLs (low-density lipoproteins) in asymptomatic 
elderly people at high cardiovascular risk [153]. Both β-sitosterol and FAs (oleic 
acid and PUFAs) can act as signaling molecules for the transcriptional repression 
of NPC1L1 in the intestine and liver [154]. These pathways lead to the insertion 
of β-sitosterol and, eventually, other phytosterols into membranes and the 
partial replacement of cholesterol. 
 
β-Sitosterol has lower condensing and ordering potency than cholesterol in 
binary and multicomponent model membranes composed of 
phosphatidylcholine, sphingomyelin, ganglioside, and/or ceramide [155]. In 
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conjunction with the similar in-plane organization of β-sitosterol and β-
sitostanol (a saturated form of β-sitosterol) in Langmuir monolayers of 
glycerophospholipids [155, 156], these data suggest that the alkyl tail, rather 
than the ring structure, in β-sitosterol accounts for the difference in membrane 
organization compared with cholesterol. Interestingly, disturbances in the 
molecular packing and morphology of model membranes due to the replacement 
of cholesterol by β-sitosterol are more pronounced when glycerophospholipids 
have MUFA chains compared with SFA chains [156]. Accordingly, atomistic 
molecular dynamics simulation studies on lipid matrices reminiscent of rafts 
(rich in saturated lipids) or less ordered membranes (rich in unsaturated lipids) 
have shown that the lower cholesterol tilt and the best ordering as a function of 
tilt in saturated bilayers promotes higher ordering of the neighboring acyl chains 
[157, 158]. As expected, phytosterols are inferior to cholesterol in promoting the 
formation of membrane domains and can inhibit the incorporation of exogenous 
cholesterol into lipid rafts at a molar ratio of 1:4 (cholesterol:phytosterol) [159]. 
Therefore, the incorporation of increasing amounts of phytosterols into bilayers 
could gradually diminish the l0 phase. The magnitude of these effects depends on 
the geometry of the phytosterol because the transition temperature from the 
lamellar to L phase in bilayer vesicles is reduced according to the following 
order of strength (compared to cholesterol): β-sitosterol > stigmasterol > 
campesterol > cholesterol [160]. This indicates that β-sitosterol is the least 
favorable phytosterol for stabilizing the interactions of lipid molecules 
constituting membranes. In binary phosphatidylcholine/sphingomyelin model 
membranes, β-sitosterol also induces a stronger contraction of area per lipid 
than stigmasterol [161]. 
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The cholesterol-lowering effects of phytosterols (mainly β-sitosterol) in plasma 
and cell membranes have been shown to maintain cardiovascular health [162-
164]. Circulating β-sitosterol, Δ5-avenasterol, and campesterol are biomarkers 
for predicting glucose intolerance, and Δ5-avenasterol and campesterol confer 
lower risk for type 2 diabetes [165]. Furthermore, several studies have reported 
that phytosterol and, in particular, β-sitosterol supplementation replaces 
cholesterol and reduces growth and survival signals routed through caveolar 
rafts in membranes of several cancer cell lines [155, 156]. In some types of 
cancer, the feedback regulation of cholesterol absorption and the lost of 
endogenous cholesterol synthesis result in the formation of regions prone to 
lipid raft development in the membranes of cancer cells [166-168]. Among the 
many mechanisms by which phytosterols exhibit anti-cancer activity in vitro are 
the modulation of ceramide metabolism, liver X receptor activation, cell cycle 
progression, and apoptosis [169]. 
 
In mice, increased circulating levels of phytosterols result in elevated levels of 
phytosterols in the brain, most likely via delivery to the endothelial cells of the 
blood-brain barrier followed by subsequent re-secretion from the basolateral 
plasma membrane [170]. This accumulation of β-sitosterol is relatively lower 
than campesterol, and the process is virtually irreversible [171]. Within the 
brain, in a cell-type specific manner, β-sitosterol can modulate the expression of 
genes involved in lipid uptake and metabolism. The substitution of 
approximately 10% of membrane cholesterol by β-sitosterol reduces processing 
of -secretase-mediated amyloid precursor protein (APP) in lipid rafts and 
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promotes the specific re-distribution of APP, which impedes its cleavage by -
secretase, in non-raft regions of hippocampal cells [172]. Studies of platelets, 
which contain more than 95% of circulating APP, have revealed that β-sitosterol 
displaces cholesterol from lipid rafts, inhibits high-cholesterol-induced platelet 
amyloid- peptide efflux, and increases pathways (- and -secretase activities) 
for APP processing [173]. β-Sitosterol also enhances mitochondrial function by 
promoting inner mitochondrial membrane fluidity in hippocampal cells [174]. 
These anti-amyloidogenic and brain ATP-preserving/boosting effects of β-
sitosterol suggest its potential for use in the prevention and management of 
neurodegenerative diseases such as AD. 
 
4.4. Erythrodiol, uvaol, oleanolic, and maslinic acids 
Naturally occurring triterpenic compounds in the form of dialcohols (erythrodiol 
and uvaol) or acids (oleanolic and maslinic acids) are composed of 30-carbon 
atom skeletons structured as 5 6-membered rings. Erythrodiol and uvaol are 2 
triterpenic compounds that are widely distributed in the plant kingdom, either in 
free form or esterified with FAs, whereas oleanolic acid and maslinic acid are 
found as free acids or as part of triterpenoid saponins. In the olive fruit, the 
methyl group at the 28-carbon atom of - and -amyrins can be substituted by a 
hydroxymethyl group to give uvaol and erythrodiol or by a carboxylic group to 
give ursolic and oleanolic acids. An additional hydroxyl group at the 2-carbon 
atom of oleanolic acid yields maslinic acid [175]. Therefore, uvaol (ursan-12-en-
3,28-diol) and ursolic acid (ursan-12-en-3-ol-28-oic acid) have the carbon 
skeleton of ursane (derived from -amyrin), whereas erythrodiol (olean-12-en-
3,28-diol), oleanolic acid (olean-12-en-3-ol-28-oic acid), and maslinic acid 
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(olean-12-en-2,3-diol-28-oic acid) have the carbon skeleton of oleanane 
(derived from -amyrin). Erythrodiol and uvaol account for approximately 60% 
and 40% of triterpenic dialcohols, respectively. Oleanolic and maslinic acids 
account for 98-99% of mono- and di-hydroxy pentacyclic triterpenic acids. The 
complete sequence of these reactions occurs in the green epicarp of the olive 
fruit as well as in the leaf and are significantly influenced by olive variety and the 
progression of olive fruit or leaf ontogeny [146, 147, 176, 177]. Together with 
sterols, erythrodiol and uvaol are relevant markers for authenticating the 
genuine virgin olive oil and detecting adulteration. The sum of erythrodiol and 
uvaol in virgin olive oil must be less than 4.5% of the total sterol content [149]. 
The concentrations of these non-steroidal triterpenic compounds in virgin olive 
oil are approximately 75 mg/kg erythrodiol, 20 mg/kg uvaol, 100 mg/kg 
oleanolic acid, 50 mg/kg maslinic acid, and 4 mg/kg ursolic acid [147, 178]. 
 
Pentacyclic triterpenic acids alter the membrane phase properties induced by 
cholesterol; the anisotropy and the nonuniformity of the bilayer environment 
also influence the relative position of pentacyclic triterpenic acids in synthetic 
model membranes [179]. Ursolic and maslinic acids partition into fluid lipid 
domains close to the membrane-water interface and compete with cholesterol to 
form hydrogen bonds with carbonyl oxygen atoms in neighboring lipid acyl 
chains. This partitioning induces the segregation of cholesterol within the bilayer 
and inverted micellar (HII phase) structures. By contrast, oleanolic acid 
penetrates more deeply into membranes, may adopt a parallel stacking 
conformation [180], and acts to alter the presence of l0 cholesterol-rich domains. 
In the membranes of human keratinocytes, oleanolic and ursolic acids are 
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integrated to a similar extent into lipid rafts, but only oleanolic acid has the 
ability to inhibit the release of ceramides in response to UVA radiation [181]. 
Structure-activity analysis indicates that chemical functions at key positions on 
ring E (a carboxylic group at the 17-carbon atom, which is near 2 methyl groups 
on the 20-carbon atom) are essential for enabling lipid raft stabilization by tight 
packing of oleanolic acid with sphingolipids in a manner resembling that of 
cholesterol. In agreement, the geminal methyl groups in the oleanane scaffold 
contribute differently to the efficiency of biological activities when compared to 
the vicinal methyl groups in the ursane scaffold [182]. Ceramides from plasma 
membrane-localized sphingomyelin immediately self-associate and form 
ceramide-enriched membrane domains [183] . This raft fusion not only 
facilitates cholesterol efflux and the replacement of cholesterol by ceramides in 
rafts [184] but also facilitates cell death pathways [185]. Substantial amounts of 
ceramide, either by de novo synthesis or via the action of acid or neutral 
sphingomyelinase, are present in isolated rafts/caveolae, even in stimulated cells 
[186]. Therefore, membrane ordering by oleanolic acid could be a mechanism for 
limiting the transverse motion of ceramide molecules as well as signaling that 
stems from these domains. 
 
Pentacyclic triterpene dialcohols and acids have been shown to decrease in vitro 
LDL susceptibility to oxidation [187], in vitro membrane lipid peroxidation [188, 
189], plasma lipid levels and blood pressure [190, 191] (by promoting nitric-
oxide-dependent vasorelaxation [192, 193]) in experimental hypertension, and 
ex vivo secretion of pro-inflammatory cytokines in human peripheral blood 
mononuclear cells [194]. These molecules also have vasodepressor, cardiotonic, 
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and antidysrhythmic activity in animal models [195] and modulate 
prostaglandin I2 synthesis in human coronary smooth muscle cells [196]. The 
potency in protecting LDLs against oxidation is as follows: maslinic acid > uvaol 
> erythrodiol [187]. Maslinic acid and uvaol block LDL binding sites prone to 
oxidative processes, but maslinic acid also scavenges free radicals. Uvaol and 
erythrodiol are the most effective in preventing LDL-supported thrombin 
generation. Oleanolic acid has protective effects against hepatic insulin 
resistance [197], inflammation [198, 199], and thrombosis [198] and is a potent 
endogenous agonist of the G-protein-coupled bile acid receptor TGR5 a novel 
pharmacological target for the treatment of metabolic syndrome [200] via 
activation of subunit Gs in lipid rafts [201]. Recent evidence suggests a relevant 
role for oleanolic acid in the prevention of type 2 diabetes because the regular 
consumption of virgin olive oil enriched in oleanolic acid improved outcomes in 
prediabetic patients with impaired fasting glucose and impaired glucose 
tolerance [202]. In addition, erythrodiol, uvaol, oleanolic, and maslinic acids 
inhibit the growth of tumor cell lines from various human cancers, including 
colon, brain, and breast cancer [203-207]. Oleanolic acid can suppress migration 
and invasion [208] and potentiate the radiosensitivity [207] of tumor cells and 
enhance the activity of antitumor drugs [209]. Due to the high tumor uptake and 
tumor-specific targeting of oleanolic acid, new hybrid radiolabeled nanoparticles 
containing oleanolic acid have been experimentally used in an all-in-one 
multimodal imaging system for the diagnosis and therapeutic monitoring of 
tumors [210]. Erythrodiol and oleanolic acid are also effective against 
experimental autoimmune encephalomyelitis by restricting the infiltration of 
inflammatory cells into the central nervous system and preventing disruption of 
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the blood-brain barrier, suggesting their potential for the prevention and 
management of multiple sclerosis and other autoimmune and/or neuro-
inflammatory diseases [211]. 
 
4.5. Secoiridoids, phenyl-alcohols, phenyl-acids, 
hydroxyisochromans, flavonoids, and lignans 
Among secondary metabolites, phenolic compounds are the most widely 
distributed in plants, with more than 8000 phenolic structures known. Phenolic 
compounds are ubiquitous in all plant organs and are involved in the defense 
against UV radiation, extreme thermal conditions, and aggression by pathogens 
or predators, tolerance to water shortage, allelopathy, soil microbial activity, 
organic matter decomposition, and mineralization. Phenolic compounds possess 
one or more aromatic rings with one or more hydroxyl groups. 
The phenolic fraction in virgin olive oil (and olive leaf) contains at least 36 
structurally different phenolic compounds, which can be divided into 6 major 
groups based on similarities in structure: secoiridoids, phenyl-alcohols, phenyl-
acids, hydroxyisochromans, flavonoids, and lignans [212-215]. Different factors 
have an influence on the variability and concentration of phenolic compounds in 
virgin olive oil, which may exceed 1500 mg/kg, including the cultivar (variety 
and age) and region of olive tree growth, olive fruit maturation, and virgin olive 
oil processing [216, 217]. The secoiridoids are typical in the botanical family of 
Oleaceae, which includes O. europaea L (olive tree) and may account for more 
than 80-90% of the total phenolic compounds in virgin olive oil. The most 
abundant secoiridoids in virgin olive oil are the dialdehyde form of 
decarboxymethyl elenolic acid linked to hydroxytyrosol, the dialdehyde form of 
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decarboxymethyl elenolic acid linked to tyrosol, oleuropein aglycone (elenolic 
acid linked to hydroxytyrosol), ligustroside aglycone (elenolic acid linked to 
tyrosol), and hydroxytyrosol acetate (up to 600, 400, 300, 50, and 15 mg/kg, 
respectively). The predominant phenyl-alcohols in virgin olive oil are 
hydroxytyrosol (3,4-dihydroxyphenylethanol) and tyrosol (4-
hydroxyphenylethanol) (up to 200 and 180 mg/kg, respectively). 
Hydroxycinnamic structures (which contain 9 carbon atoms, C6-C3) and 
hydrobenzoic structures (which contain 7 carbon atoms, C6-C1) comprise the 
phenyl-acids found in virgin olive oil, which include p-coumaric, o-coumaric, 
caffeic, ferulic, sinapic, gallic, gentisic, syringic, vanillic, protocathechuic, and p-
hydroxybenzoic acids (up to 4 mg/kg per analyte). Two hydroxyisochromans 
formed by the reaction of hydroxytyrosol with benzaldehyde (1-phenyl-6,7-
dihydroxyisochroman) or vanillin [1-(3-methoxy-4-hydroxy-phenyl)-6,7-
dihydroxyisochroman] have also been identified in virgin olive oil (up to 0.4 and 
1.5 mg/kg, respectively). The structure of flavonoids is based on a flavan nucleus 
consisting of 3 phenolic rings referred to as the A, B, and C rings. Variations in 
the heterocyclic C ring give rise to the main groups of flavonoids: flavones, 
flavanols, flavonols, flavanones, isoflavones, and anthocyanins. The major 
flavonoids in virgin olive oil are the flavones luteolin and apigenin (up to 10 and 
3 mg/kg, respectively) and the flavonol quercetin (up to 1 mg/kg). (+)-
Pinoresinol, 1-(+)-acetoxypinoresinol, and 1-(+)-hydroxypinoresinol are the 
most common lignans in virgin olive oil (up to 180, 80, and 20 mg/kg, 
respectively). The phenolic fraction plays a significant role in the sensory 
properties (bitterness, pungency, and astringency) of virgin olive oil and in the 
protection and stability of virgin olive oil against oxidation. Secoiridoids may 
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undergo hydrolysis under gastric conditions, resulting in significant increases in 
the amounts of hydroxytyrosol and tyrosol [13, 218] and, to a lesser extent, 
oleuropein and oleuropein aglycone [219, 220] entering the small intestine. 
Secoiridoids exhibit an absorption efficiency of approximately 55 to 66% and an 
excretion rate of only 5 to 16% of the total amount ingested [221]. A wide range 
of different phenolic compounds has been detected in multiple animal tissues, 
including brain tissue, after a single ingestion of the phenolic compounds found 
in virgin olive oil [222]. 
 
Studies of unilamellar membranes have revealed that phenolic compounds (the 
dialdehyde form of decarboxymethyl elenolic acid linked to hydroxytyrosol, 
oleuropein aglycone, oleuropein, hydroxytyrosol, and hydroxytyrosol acetate) 
remain at the lipid membrane surface area, almost parallel to the bilayer, which 
they do not penetrate [223]. This is most likely due to the hydrophilic properties 
and the conformational mobility of phenolic non-planar structures, in contrast to 
hydroxyisochromans with planar and lipophilic phenyl substituents, which 
favors the deeper membrane localization of the phenolic molecule [224]. In 
phospholipid/water systems, oleuropein exhibits a high affinity for phospholipid 
acyl chains, promoting no major changes in the gel-to-L phase transition and a 
tendency to form inverted HII phase structures in zwitterionic phospholipid-
containing membranes but inducing dramatic perturbations at the surface of 
membranes formed with negatively charged phospholipids [225]. Similar 
membrane localization and interaction, with most of the molecule exposed to the 
aqueous phase, have been reported for flavonoids, including luteolin [226] and 
quercetin [227]. Incorporation of phenolic compounds into the membrane may 
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induce a deformation of the membrane surface toward a negative membrane 
curvature. Therefore, the accommodation of lipid membrane dynamics by 
phenolic compounds dictates the ability of phenolic compounds to delay lipid 
peroxidation by trapping peroxyl radicals from the aqueous phase and to 
prevent the propagation cycle of lipid peroxidation from the interface to the 
inner membrane. This response may be heightened by cross-talk with 
hydrophilic, amphipathic, and/or hydrophobic natural antioxidants, including 
other phenolic compounds. The combination of phenolic compounds with 
ascorbate or -tocopherol has an additive or synergistic effect against oxidative 
stress on membranes [223]. Phenolic compounds also contribute to the 
regeneration and conservation of -tocopherol molecules [228, 229]. Oleuropein 
aglycone, oleuropein, and/or hydroxytyrosol confer antioxidant protection 
against oxidative injury in membranous systems, including human red blood 
cells [230], liver cells [231], and retinal pigment epithelial cells [232]. The 
antioxidant mechanisms of phenolic compounds include reduction of oxygen 
concentration, termination of free radicals, decomposition of primary products 
of oxidation to non-radical species, and prevention of continuous hydrogen 
abstraction from substrates and chelators of metal ions [233]. Independent of 
redox-sensitive processes, phenolic compounds may exert additional biological 
activities at the membrane level. For example, oleuropein may entropically 
interfere with the in vitro aggregation of islet amyloid polypeptide (amylin) in 
the membrane of human pancreatic -cells, thereby avoiding the toxic effects of 
amylin aggregates, which often involve nonspecific membrane permeabilization 
and destruction of pancreatic -cells [234, 235]. The pore-forming effect of -
synuclein oligomers on synthetic membrane vesicles can be similarly prevented 
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by apigenin, which contains a critical dihydroxyphenyl ring structure, alone or as 
part of the flavone scaffold [236]. In vivo, oleuropein also plays a role in blocking 
the membrane stressor activity of amyloid- peptide aggregates in an 
invertebrate model of AD and musculoskeletal degenerative diseases such as 
inclusion body myositis [237]. Studies of the interaction of phenolic compounds 
with integral membrane proteins indicate that hydroxytyrosol may accelerate 
the oscillation of the norepinephrine transporter between the outward-facing 
mode (accessible to the extracellular medium) and the inward-facing mode 
(open to the intracellular milieu) in an in vitro model of differentiated 
sympathetic neurons [238]. 
 
Prospective epidemiological studies, some randomized prevention trials, and 
many short-term studies of intermediate endpoints suggest that the intake of 
virgin olive oil phenolic compounds in combination with oleic acid may 
protect against cardiovascular diseases [3, 14, 239-243] and different types of 
cancer [13, 216, 240, 241, 244, 245] via synergistic and overlapping protective 
antioxidant and anti-inflammatory effects as well as other effects yet to be 
identified. The plasma incorporation of phenolic compounds following virgin 
olive oil intake has been shown to improve antioxidant status in elderly people 
[246] and endothelial dysfunction in patients with early atherosclerosis [247]. In 
vitro, phenolic compounds can regulate genes involved in nitric oxide 
metabolism, proteolysis of connective tissues, differentiation coupled to 
membrane-bound oxidases, and nuclear factor-B (NF-B) signaling [248, 249]. 
The cooperation of hydroxytyrosol + tyrosol or p-coumaric + caffeic acid 
diminishes homocysteine-induced endothelial dysfunction by inhibiting 
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adhesion molecules in a redox-independent manner [250], whereas the 
cooperation of hydroxytyrosol + caffeic acid protects DNA from oxidative 
damage while exerting an antiproliferative effect on tumor cells [251]. Similar 
cellular effects, including reduced reactive oxygen species (ROS) and reduced 
proliferation, have been reported for caffeic, syringic, and protocathechuic acids 
[252]. Recent evidence also suggests that luteolin inhibits human prostate tumor 
growth by suppressing vascular endothelial growth factor 2-mediated 
angiogenesis [253] and apoptosis [254]. Other in vitro anticancer effects of 
luteolin include irreversible changes in mitochondrial membrane 
structure/function [255] and the reversal of the epithelial-mesenchymal 
transition [134], which may act in concert with the ability of luteolin to enhance 
the activity of antitumor drugs [256]. In addition, ferulic acid potentiates the 
radiosensitivity of human cervical carcinoma cells [257]. Secoiridoids, 
flavonoids, and lignans strongly inhibit the overexpression of fatty acid synthase 
[258] and the proto-oncogene HER2 (human epidermal growth factor receptor 
2) [259] in tumor cells. Hydroxytyrosol, tyrosol, caffeic acid, and (+)-pinoresinol 
exert anticancer effects by inhibiting invasion [260] and selectively activating the 
ataxia telangiectasia mutated-p53 cascade [261]. Additional novel health effects 
and mechanisms of phenolic compounds found in virgin olive oil are rapidly 
being identified. In vitro, hydroxytyrosol, tyrosol, 1-(+)-acetoxypinoresinol, 
oleuropein aglycones, and notably, the dialdehyde form of decarboxymethyl 
elenolic acid linked to tyrosol have strong activity against Helicobacter pylori 
[262]. These results are in agreement with the observation that the 
administration of virgin olive oil rich in phenolic compounds is moderately 
effective in eradicating H. pylori in patients with H. pylori-positive status [263]. 
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This suggests a potential role for these phenolic compounds as chemo-
preventative agents for peptic or gastric ulcers. Oleuropein operates at a dose 
one order of magnitude lower than ranitidine in experimental injury of the 
gastric mucosa, improving the total antioxidant capacity and cell membrane 
integrity [264]. Hydroxytyrosol has antifungal activity [265], and luteolin exerts 
antibacterial and synergistic activity by altering outer and inner membrane 
permeability in amoxicillin-resistant Escherichia coli [266]. Oleuropein has lipid-
lowering effects and confers protection against SFA (palmitic acid)-induced 
hepatocellular steatosis [267]. The supplementation of diets with hydroxytyrosol 
improves the inflammatory response in experimental models of chronic colonic 
inflammation with clinical and histological similarity to human ulcerative colitis 
[268]. Tyrosol has a protective effect against mitochondrial dysfunction-induced 
dopaminergic neuronal death via activation of the phosphoinositide 3-kinase 
(PI3K)/PKB signaling pathway, along with up-regulation of antioxidant enzymes 
in an in vitro model of AD [269]. In mitochondria isolated from the hippocampus, 
cortex, and striatum of transgenic mice doubly expressing amyloid- precursor 
protein and presenilin 1, luteolin nearly completely restores mitochondrial 
function by a mechanism associated with ROS scavenging and/or stabilization of 
the electron transport chain [270]. Luteolin also confers protection against ER 
stress-induced neuronal cell death in the hippocampus in an experimental 
corticosterone-treated depression model [271]. Phenolic acids and flavonoids 
are active in the prevention or delay of cataract development [272]. Luteolin 
inhibits NF-B binding activity and the activator-protein-1 pathway as well as 
their downstream target genes in gestational tissues, reducing the secretion of 
pro-inflammatory cytokines, prostaglandins, and metalloproteinases in fetal 
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membranes, amnion, and myometrial cells exposed to pro-inflammatory stress 
[273], indicating a potential therapeutic use of luteolin in pre-term birth. The 
plethora of beneficial effects associated with the phenolic compounds described 
above supports the potential of virgin olive oil in treating metabolic syndrome, 
as well as infectious, neurodegenerative, and autoimmune diseases, all of which 
are reaching pandemic levels and increasingly affecting human life. In 2011, 
following a request from the European Commission, the Panel on Dietetic 
Products, Nutrition and Allergies of the European Food Safety Authority 
concluded that a cause and effect relationship had been established between the 
consumption of virgin olive oil polyphenols (standardized by the content of 
hydroxytyrosol and its derivatives) and the protection of LDL particles from 
oxidative damage [274]. There is the hope that new health claims related to 
virgin olive oil consumption will be recognized in the near future. 
 
4.6. Tocopherols and tocotrienols 
Essential in the human diet, vitamin E is a general term that is used to describe a 
family of 8 different, naturally occurring forms: 4 tocopherols (-, -, -, and -
tocopherols) and 4 tocotrienols (-, -, -, and -tocotrienols). A chromanol ring 
bearing a phenolic group and a lipophilic side chain are the functional domains 
of vitamin E [275, 276]. The number of methyl groups attached at the 5-carbon 
atom and/or 7-carbon atom on the chromanol ring, in addition to a common 
methyl group at the 8-carbon atom, designates each form. The  form is the most 
highly methylated, with a maximum of 3 methyl groups on the chromanol ring, 
compared with the  and  forms, which have 2 methyl groups (the common 
methyl group and one at the 5-carbon atom or 7-carbon atom, respectively), and 
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the  form, which contains only the common methyl group on the chromanol 
ring. Structurally, tocopherols and tocotrienols differ in the branched side chain 
at the 2-carbon atom, which is a saturated isoprenoid C16 side chain in 
tocopherols and a farnesyl isoprenoid side chain with trans double bonds at the 
3’-, 7’-, and 11’-carbon atoms in tocotrienols. -Tocopherol is the most 
biologically active form of vitamin E and accounts for nearby 95% of the total 
vitamin E found in virgin olive oil (up to 300 mg/kg). The concentrations of the 
different forms of vitamin E in virgin olive oil are approximately 300 mg/kg -
tocopherol, 3 mg/kg -tocotrienol, 4 mg/kg -tocopherol, 1 mg/kg -tocotrienol, 
2 mg/kg -tocopherol, 12 mg/kg -tocopherol, and 5 mg/kg -tocotrienol. 
Different factors influence the variability and concentration of tocopherols in 
virgin olive oil, including the cultivar (variety and age) and region of olive tree 
growth, olive fruit maturation, harvesting and processing conditions, and virgin 
olive oil storage conditions [277-284]. These natural antioxidants not only 
provide nutritional value to virgin olive oil but also contribute to its stability 
with respect to oxidation, even during heating at frying temperature, thereby 
preserving its quality. 
 
Among the members of the vitamin E family of compounds, -tocopherol is 
selectively enriched in the plasma and tissues via independent activities of a 
hepatic -tocopherol transfer protein that retains -tocopherol, as well as the 
catabolizing cytochrome P-450 system, which preferentially degrades all other 
forms of vitamin E [285]. The lipophilic side chain enables the anchoring and 
penetration of tocopherols and tocotrienols into biological membranes, where 
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they function as chain-terminating hydrogen atom donors to lipid peroxy 
radicals [286-289]. Tocopherols and tocotrienols are inserted into one leaflet of 
the lipid bilayer, parallel to membrane phospholipid chains with the active 
hydroxyl group at the lipid-water interface, and exert mainly the same mobility 
[290]. They show preferential affinity for and co-localize with PUFAs and 
partition into non-raft domains rich in PUFAs [288]. This orientation and 
localization influence membrane conformational dynamics; in some cases, 
tocopherols modulate the structure of unsaturated phospholipid bilayers in a 
similar manner as cholesterol in lipid rafts [291]. At membrane tocopherol 
concentrations above 10 mol%, the main transition temperature decreases 
continuously in a concentration-dependent manner, except for - and -
tocopherols, which stabilize a modulated P phase (in between the gel-to-L 
phase transition). -Tocopherol fluidizes the bilayer more efficiently than - and 
-tocopherols but not as efficiently as cholesterol. At a narrow composition 
range between 7.5 and 10 mol% and coupled to the bilayer curvature, 
tocopherols favor the asymmetric ripple P’ phase, which is characterized by 
corrugations of the membrane surface with well-defined periodicity and a 
bilayer thickness that is different in the 2 arms of the ripple and increases with 
increasing tocopherol concentration in the membrane. By contrast, tocotrienols 
are more readily transferred to membranes and cause more minor ordering 
disturbances than tocopherols. This intricate arrangement of tocopherols and 
tocotrienols in membranes optimizes protection against peroxy-radicals created 
within PUFA chains as well as the regeneration of tocopheroxyl/tocotrienoxyl 
radicals by water-soluble reducing agents such as ascorbate and phenolic 
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compounds; such arrangement has membrane-stabilizing and reparative effects 
[292]. 
 
Evidence suggests that corresponding tocopherols and tocotrienols display 
similar potency for radical scavenging in homogenous solution systems and 
liposomal membranes [293, 294]. The hydrophobic prenyl chain in the different 
vitamin E forms appears not to significantly affect hydrogen donor propensities, 
which increase with increasing methylation degree of the chromanol ring ( >  
=  > ). Thus, a high plasma concentration of vitamin E, implying a high total 
plasma antioxidant capacity, has been associated with lower risks of 
cardiovascular disease and some types of cancer [275, 295, 296]. Vitamin E has 
also been shown to play a critical role in central nervous system health. The 
therapeutic benefit of vitamin E is related to the prevention and management of 
neurodegenerative disorders such as AD and Parkinson’s disease [297, 298]. 
Moreover, increasing evidence suggests novel mechanisms of action for vitamin 
E independent of antioxidant activity and a different spectrum of biological 
activities for tocopherols and tocotrienols [299, 300]. 
 
5. Conclusions and future directions 
The role of evolution in creating lipid bilayers to allow for the interaction of cells 
with the environment is interesting. This review provides compelling evidence 
regarding how oleic acid and the minor constituents of virgin olive oil interact 
with and regulate the functions of membranes. Oleic acid can be efficiently 
incorporated into phospholipids, forming the core of the lipid bilayer and 
regulating the activity of integral or peripheral membrane proteins. Minor 
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constituents exhibit a wide range of lipophilicity, which causes preferential 
localization of these constituents within the membrane or on the bilayer/water 
interface (Fig. 5). Despite the low concentrations of some minor constituents of 
virgin olive oil, their spatial confinement in the membrane may greatly enhance 
their local concentration, synergy, and co-localization in relevant regions or 
microdomains. However, further work needs to be done to confidently establish 
that oleic acid and the minor constituents of virgin olive oil are absorbed, 
metabolized, and directed to target membranes while retaining their therapeutic 
benefits, as well as to gain mechanistic insights into the multilateral and 
cooperative actions of these bioactive entities in membrane lipid and protein 
dynamics in health and disease. 
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Figure captions 
 
Fig. 1. Chemical structures of squalene, carotenoids, sterols, triterpenic 
dialcohols, and triterpenic acids in virgin olive oil. 
 
Fig. 2. Chemical structures of secoiridoids, phenyl-alcohols, and phenyl-acids in 
virgin olive oil. 
 
Fig. 3. Chemical structures of hydroxyisochromans, flavonoids, lignans, 
tocopherols, and tocotrienols in virgin olive oil. 
 
Fig. 4. Chemical structures of glycerophospholipids and sphingolipids containing 
oleic acid chains. 
 
Fig. 5. Schematic representation illustrating the estimated positions of oleic acid 
and various minor constituents of virgin olive oil in a membrane. Lipid-water 
interfaces are shown in yellow. The chemical structures were obtained from the 
3D Conformer utility in the PubChem Structure database 
(http://pubchem.ncbi.nlm.nih.gov/search/search.cgi#). 
Table 1 
Chemical structure and range of major fatty acids in virgin olive oil. 
 
Fatty acid 
Regulations1 
(%) 
16:0, palmitic acid 7.5-20.0 
  
16:1n-7, palmitoleic acid 0.3-3.5 
  
18:0, stearic acid 0.5-5.0 
  
18:1n-9, oleic acid 55.0-83.0 
  
18:2n-6, linoleic acid 3.5-21.0 
 
 
18:3n-3, -linolenic acid ≤ 1.0 
  
MUFAs, monounsaturated fatty acids 53-87 
SFAs, saturated fatty acids 8-26 
PUFAs, polyunsaturated fatty acids 3-22 
 
1International Olive Oil Council (www.internationaloliveoil.org). 
 
 
Table 1
Table 2 
Mean values of major fatty acids in several human tissues. 
aSkeletal muscle triglycerides. 
bSkeletal muscle phospholipids. 
cHeart phosphatidylcholine. 
dFrontal neocortex (similar mean values are found in temporal and parietal neocortex). 
eErythrocyte phosphatidylcholine. 
n.d., not determined. 
Fatty acid 
Subcutaneous 
adipose tissue 
[ref. 19] 
Skeletal 
musclea 
[ref. 20] 
Skeletal 
muscleb 
[ref. 20] 
 
Heartc 
[ref. 21] 
 
Aorta 
[ref. 22] 
 
Liver 
[ref. 19] 
 
Braind 
[ref. 23] 
Cerebrospinal 
fluid 
[ref. 24] 
Whole 
blood 
[ref. 24] 
 
Erythrocytee 
[ref. 25] 
14:0, myristic acid 
16:0, palmitic acid 
16:1n-7, palmitoleic acid 
18:0, stearic acid 
18:1n-9, oleic acid 
18:2n-6, linoleic acid 
18:3n-3, -linolenic acid 
20:3n-6, dihomo--linolenic acid 
20:4n-6, arachidonic acid 
20:5n-3, eicosapentaenoic acid 
22:6n-3, docosahexaenoic acid 
 
2 
22 
6 
3 
50 
11 
1 
0.3 
0.6 
0.1 
0.3 
 
3 
23 
5 
6 
51 
10 
0.8 
0.2 
0.3 
ND 
0.4 
 
0.7 
23 
0.6 
18 
15 
30 
0.3 
1 
10 
1 
2 
 
1 
27 
0.8 
6 
12 
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0.2 
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16 
0.4 
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5 
22 
n.d. 
8 
31 
9 
8 
n.d. 
3 
3 
n.d. 
 
2 
28 
4 
8 
35 
12 
0.9 
0.8 
4 
0.5 
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0.7 
21 
2 
21 
17 
0.9 
n.d. 
1 
9 
n.d. 
15 
 
n.d. 
28 
3 
19 
25 
7 
3 
1 
3 
2 
1 
 
n.d. 
23 
3 
9 
21 
20 
0.7 
2 
8 
2 
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n.d. 
35 
n.d. 
11 
18 
19 
0.2 
n.d. 
5 
1 
2 
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Dialdehyde forms of secoiridoids 
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